SUSPENSION LETTER - MAILED
mailed
on 17 Jun 2024
Last Applicant/ Owned by
Mikroforum Ring 2
Wendelsheim
DE
55234
Serial Number
88066252 filed on 06th Aug 2018
Registration Number
N/A
Correspondent Address
Lynn J. Alstadt
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
AESKUCARE
Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical use; Diagnostic reagents for in-vitro clinical laboratory use Medical, chemical and biological test kits, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing for medical purposes, and test reagents, namely, genetic identity tests comp Read More
Classification Information
Class [005]
Pharmaceutical Products
Medical, chemical and biological test kits, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing for medical purposes, and test reagents, namely, genetic identity tests comprised of reagents for medical purposes; Antiserums for diagnostic purposes; Chemical reagents for medical diagnostic, medical or veterinary purposes; Medical or veterinary chemical test reagents for medical use; Chemical test reagents for medical use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical and veterinary purposes; Diagnostic preparations for medical, pharmaceutical or veterinary purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic testing materials for medical use, namely, medical diagnosis test strips for blood analysis or bodily fluids analysis; Diagnostic reagents for medical use; Diagnostic substances for medical use; Immunoassay reagents for medical or medical diagnostic purposes; In vitro diagnostic preparations for medical use; Indicators for medical diagnosis, namely, diagnostic preparations for medical purposes; Medical diagnostic test strips for blood analysis or bodily fluids analysis; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents; Preparations of microorganisms for medical or veterinary use; Preparations for detecting genetic predispositions for medical purposes; Preparations for detecting mutation in prion genes for medical purposes; Chemical reagents for use in analysis for veterinary purposes; Chemical reagents for analysis purposes for medical diagnostic, medical or veterinary purposes; Reagents for use in diagnostic tests comprised of veterinary diagnostic reagents; Diagnostic reagents for in-vitro laboratory use for medical purposes; Diagnostic reagents for in-vitro laboratory use for veterinary purposes; Diagnostic reagents for blood grouping for medical purposes; Medical diagnostic reagents for use with testing apparatus for testing of blood analysis or bodily fluids analysis for autoimmune diseases, neurological diseases or cancer for medical or medical diagnostic purposes; Diagnostic reagents for use in diagnostic tests and analyses for testing and analysis of blood or bodily fluids for autoimmune diseases, neurological diseases or cancer for medical purposes; Diagnostic reagents for use with testing apparatus for testing of blood or bodily fluids for autoimmune diseases, neurological diseases or cancer for medical diagnostic or veterinary purposes; Reactants for medical or veterinary diagnosis, namely, diagnostic reagents for medical and veterinary uses; Veterinary diagnostic reagents; Clinical medical reagents; Biological reagents for medical, medical diagnostic and veterinary purposes; Chemical reagents for medical, medical diagnostic and veterinary purposes; Chemical reagents for medical and veterinary purposes; Reagents for microbiological analysis, for medical or veterinary purposes; Genetic identity tests, consisting of reagents for medical purposes; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; Reagents for medical and veterinary genetic testing; Chemical preparations for use in DNA analysis for medical use; Chemical preparations for medical and medical diagnostic purposes, namely, for autoimmune diseases, neurological diseases or cancer; Blood for medical purposes, and blood plasma for medical diagnostic purposes; Biological preparations for medical, medical diagnostic and veterinary purposes for the treatment of autoimmune diseases, neurological diseases or cancer; Mixed biological preparations for medical and medical diagnostic purposes for the prevention and treatment of infectious diseases; Blood plasma; Blood components, namely, platelet rich blood plasma and stem cells for medical use; Blood protein fractions, namely, blood plasma fractions or bodily fluid fractions for medical diagnostic purposes and medical therapeutic purposes; Enzymes for medical, medical diagnostic and veterinary purposes; Enzyme preparations for medical and veterinary purposes; By-products of the processing of cereals for medical and medical diagnostic purposes; Nucleic acid sequences for medical diagnostic, medical and veterinary purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical use; Diagnostic reagents for in-vitro clinical laboratory use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 88066252
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
Yes
44D Current
Yes
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Jun 2024 | ASSIGNED TO LIE |
| 17th Jun 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 17th Jun 2024 | SUSPENSION LETTER WRITTEN |
| 17th Jun 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 17th Jun 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 17th Jun 2024 | LETTER OF SUSPENSION E-MAILED |
| 19th Feb 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 20th Nov 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| 20th Nov 2023 | INQUIRY TO SUSPENSION E-MAILED |
| 20th Nov 2023 | SUSPENSION INQUIRY WRITTEN |